Explore AstraZeneca PLC's August 2025 6-K report detailing Capital Group's voting rights change, reflecting shareholder dynamics and compliance with SEC regulations.
Explore AstraZeneca PLC's Form 6-K detailing issued share capital, total voting rights, and regulatory compliance for investors and analysts.
Explore AstraZeneca PLC's financial report detailing 1.55B voting rights, regulatory compliance, and company overview. Key insights for shareholders and stakeholders.
Explore AstraZeneca PLC's Form 6-K for March 2025, detailing the AGM on April 11, 2025, key business to be conducted, and voting information for shareholders.
Explore Indivior PLC's January 2025 Form 6-K report detailing total voting rights, essential for shareholders. Signed by Kathryn Hudson, it's crucial for investor understanding.
Explore Nexxen International Ltd.'s January 2025 Form 6-K detailing Total Voting Rights, shareholder governance, and regulatory compliance.
Ryanair Holdings PLC's Form 6-K reveals Capital Group's voting rights drop below 13%. Key details on holdings and governance impact.
Explore key details from Fox Corporation's 8-K report on June 13, 2019, highlighting changes to the Rights Agreement, impacting shareholder rights and investment strategies.
Discover Stratasys Ltd.'s recent amendment to its Shareholder Rights Agreement, extending expiration to Dec 2025. Essential insights from SEC Form 6-K filed on Dec 20, 2024.